Pirfenidone N=96 | |
Age – years (range) | 67.1+/-8.1 (47–83) |
Male sex - no (%) | 71 (73) |
BMI (range) | 28+/-7.9 (14.4–43.4) |
Former Smokers - no (%) | 64 (66%) |
Duration of Treatment – months (range) | 9.3+/-8.3 (0–32) |
FVC% Predicted (range) | 72.9+/-23.1 (46–146) |
FVC 51–80% Predicted - no (%) | 69(72%) |
FVC >80% Predicted – no (%) | 20 (20%) |
DLCO% Predicted (range) | 43.6+/-19.9 (14–87) |
DLCO <25% Predicted or unable – no (%) | 12 (12) |
DLCO 26–35% Predicted – no (%) | 24 (25) |
DLCO 36–65% Predicted – no (%) | 45 (47) |
DLCO >66% Predicted – no (%) | 7 (7) |
Use of supplementary oxygen - no (%) | 22 (23) |
Use of prednisolone – no (%) | 26 (27) |
Use of N-acetylcysteine – no (%) | 22 (22) |
Plus-minus values are means +/-SD.